title: [Thyroid dysfunction in pregnancy].
abstract: Thyroid dysfunction may impair fertility, course of pregnancy and fetal development. Physiological alterations of thyroid function parameters, that occur during pregnancy need to be distinguished from pathophysiological states of hypo- and hyperthyroidism. We performed a literature search (PubMed 1990-2013) and review relevant publications as well as consensus and practice guidelines of international thyroid/endocrine societies. Interpretation of thyroid function values in pregnancy must be based on trimester-specific TSH and T4 ranges. Alterations in thyroid function are present in up to 15% of pregnancies (0.4% overt hypothyroidism, 0.1-0.4% hyperthyroidism) and may lead to preventable complications in the pregnant woman and the fetus. Hypothyroidism is associated with an increased risk for abortion, premature delivery and stillbirth, besides impairment of neurocognitive development. The latter has also been shown in situations of grave iodine deficiency. In addition to new-born screening directed at early recognition of congenital hypothyroidism (incidence 0.03%), universal screening of all pregnant women should be implemented in health care guidelines. Newly diagnosed overt hypothyroidism in a pregnant woman requires immediate levothyroxine substitution at adequate doses. In subclinical hypothyroidism thyroid hormone replacement should be considered. Iodine supplementation is strongly recommended in all pregnant and breast-feeding women. Pregnancy causes a number of, that need to be of thyroid dysfunction. Both hypothyroidism and thyrotoxicosis may impair the course of pregnancy and may negatively affect the fetus. In particular, maternal hypothyroidism may lead to irreparable and detrimental deficits in the neurocognitive development of the fetus. Autoimmune thyroid disease is the most common cause of thyroid dysfunction in pregnancy. Hashimoto's thyroiditis is associated with impaired fertility and miscarriage, and may first manifest in pregnancy due to the increased thyroid hormone requirement. Graves' disease often shows a characteristic course in pregnancy with amelioration of thyrotoxicosis in the second half of pregnancy and exacerbation after delivery. In addition transplacental passage of maternal TSH receptor antibodies may lead to thyrotoxicosis in the fetus and/or newborn.
authors.affiliation: Klinik für Endokrinologie und Stoffwechselerkrankungen, Universitätsklinikum Essen.
authors.forename: D
authors.identifier: 0000-0003-0357-4192
authors.initials: D
authors.lastname: Führer
authors.affiliation: Praxis für Kardiologie, Nuklearmedizin und Endokrinologiezentrum, Alter Hof München.
authors.forename: K
authors.initials: K
authors.lastname: Mann
authors.affiliation: Klinik für Allgemeine Innere Medizin, Endokrinologie, Diabetologie, Pneumologie, Infektiologie Bielefeld.
authors.forename: J
authors.initials: J
authors.lastname: Feldkamp
authors.affiliation: Klinik für Allgemeine Pädiatrie, Charité Universitätsmedizin Berlin.
authors.forename: H
authors.initials: H
authors.lastname: Krude
authors.affiliation: Medizinische Klinik und Poliklinik II, Klinikum der Universität München-Großhadern.
authors.forename: C
authors.initials: C
authors.lastname: Spitzweg
authors.affiliation: Institut für Laboratoriumsmedizin, Klinische Chemie, Molekulare Diagnostik, Universitätsklinikum Leipzig.
authors.forename: J
authors.initials: J
authors.lastname: Kratzsch
authors.affiliation: Funktionsbereich spezielle Endokrinologie, Universitätsklinikum Düsseldorf.
authors.forename: M
authors.initials: M
authors.lastname: Schott
mesh_terms: D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis* / Q000628:therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis* / Q000628:therapy*; D018570:Risk Assessment; D013959:Thyroid Diseases / Q000175:diagnosis* / Q000628:therapy*